Position in WHWK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,830,436
+$2,934,884 QoQ
Shares Held
2,849,402
0.0% QoQ
Ownership
5.76%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in WHWK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Avoro Capital Advisors LLC holds $8,549,473,651 across 28 Biotechnology names. WHWK ranks #27 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
5,062,500 | $1,157,945,625 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,818,181 | $951,763,208 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
2,888,888 | $746,257,548 | |
| 4 | ARGX |
Argenx SE
|
1,000,000 | $730,250,000 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
10,699,999 | $670,889,937 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
7,474,747 | $622,571,677 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
12,222,222 | $491,699,991 | |
| 8 | CNTA |
Centessa Pharmaceuticals plc
|
11,430,455 | $454,017,672 |
All Filings in WHWK
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-05-12 | $62,302,582 | 15,893,516 | Shares | Sole | 2026-05-14 | |
| 2026-03-31 | $9,830,436 | 2,849,402 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,895,552 | 2,849,402 | Shares | Sole | 2026-03-16 | |
| 2025-09-30 | $5,413,863 | 2,849,402 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,328,381 | 2,849,402 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,071,935 | 2,849,402 | Shares | Sole | 2025-05-15 | |
| 2025-02-28 | $24,360,453 | 9,515,802 | Shares | Sole | 2025-03-04 | |
| 2024-12-31 | $8,989,863 | 2,849,402 | Shares | Sole | 2025-02-14 | |
| 2024-12-19 | $6,610,612 | 2,849,402 | Shares | Sole | 2024-12-23 | |
| 2024-09-30 | $5,869,768 | 2,849,402 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,160,126 | 2,849,402 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,667,600 | 2,849,402 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,755,792 | 2,849,402 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $13,791,105 | 2,849,402 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $19,489,909 | 2,849,402 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $20,629,670 | 2,849,402 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $36,557,827 | 2,849,402 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $40,262,050 | 2,849,402 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $22,538,232 | 1,829,402 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $31,044,951 | 1,829,402 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $44,180,058 | 1,829,402 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $53,729,536 | 1,829,402 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||